OBJECTIVE To examine predictors of health care providers perceiving intrauterine devices (IUDs) as unsafe for nulliparous women and of infrequent provision of IUDs to nulliparous women. METHODS We analyzed questionnaire data obtained during December 2009 to March 2010 from 635 office-based providers (physicians) and 1,323 Title X clinic providers (physicians, physician assistants, certified n...

background: the levonorgestrel-releasing iud can help the treatment of dysmenorrhea by reducing the synthesis of endometrial prostaglandins as a conventional treatment. objective: this study was performed to assess the frequency of dysmenorrhea, satisfaction and quality of life in women using mirena iuds as compared to those using copper iuds. materials and methods: this double-blind randomized...

BACKGROUND The purpose of this study was to provide additional data on the experience with frameless copper and levonorgestrel (LNG) intrauterine devices (IUDs) in nulliparous and adolescent women. METHODS Nulliparous and adolescent women, 25 years of age or younger, using the frameless copper IUD or the frameless LNG-releasing intrauterine system (IUS), were selected from previous studies an...

Three intrauterine devices (IUDs) are available in the United States: the copper T 380A and two levonorgestrel-releasing IUDs, one that releases 20 mcg of levonorgestrel per 24 hours, and one that releases 14 mcg per 24 hours. All are safe and effective methods of contraception that work predominantly by prefertilization mechanisms. The copper T 380A IUD may be placed in nonpregnant women at an...

Objective: Our aim was to investigate the effects of levonorgestrel-releasing intrauterine system on the endometrium of ovariectomized rats under estrogen replacement therapy. Methods: Twenty-four Sprague-Dawley rats were divided into four groups and operated for the insertion of levonorgestrelreleasing (3 μg/day) or placebo-bearing intrauterine devices (IUD). Following the operation, the rats ...

Melasma is a common acquired hypermelanosis of the skin that has been associated with several etiologic factors including ultraviolet light exposure, pregnancy, and oral contraceptives (OCPs) (1). Forty-one percent of women surveyed in one study had onset of melasma after pregnancy, and 25% after starting an OCP (2). Women who develop melasma during pregnancy may be more susceptible to developi...

1Department of Public Health; 2Department of Epidemiology and Biostatistics, Faculty of Health, Zahedan Medical Sciences University, Zahedan, Islamic Republic of Iran. Received: 08/12/02; accepted: 13/05/03 ABSTRACT We evaluated contraception continuation rates and discontinuation reasons in Zahedan among 1741 women from 1998–2000. By Kaplan–Meier technique continuation rates were 92% for low d...

OBJECTIVE To estimate whether 6-month use of the levonorgestrel-releasing intrauterine device (IUD) would be higher when insertion occurred within 10 minutes of placental delivery compared with 6-8 weeks postpartum. METHODS We enrolled pregnant women planning vaginal deliveries and desiring a postpartum levonorgestrel-releasing IUD. Patients were randomly assigned when admitted in labor to po...

A levonorgestrel-containing intrauterine contraceptive devices are widely used in contemporary gynaecology, primarily as an effective method for contraception and control of menstrual disorders like menorrhagia dysmenorrhea. case report the uterine perforation by levonorgestrel-releasing device (LNG-IUD) a 33-year-old asymptomatic woman after 18-month insertion. On routine cervical smear examin...

OBJECTIVE The contraceptive efficacy of intrauterine devices (IUD) is thought to relate to the position of the IUD in the uterine cavity. Several trials examined the number of copper IUD expulsions, but none evaluated the partial and complete expulsion rate of the levonorgestrel-releasing device (LNG-IUD). STUDY DESIGN This retrospective cohort study compares the dislocation rate of the Multi...